Package 0078-0628-51

{"route": ["ORAL"], "spl_id": "79d3253f-e1e3-428f-8dd4-4f2fe76faa15", "openfda": {"nui": ["N0000175605", "N0000175076", "N0000182141", "N0000182137", "N0000175625", "N0000175624", "N0000175550"], "unii": ["9HW64Q8G6G"], "rxcui": ["845507", "845512", "845515", "845518", "998189", "998191", "1119400", "1119402", "1308428", "1308430", "1308432", "1310138", "1310144", "1310147"], "spl_set_id": ["2150f73a-179b-4afc-b8ce-67c85cc72f04"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["Kinase Inhibitor [EPC]", "mTOR Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Protein Kinase Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "mTOR Inhibitors [MoA]"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "28 BLISTER PACK in 1 CARTON (0078-0628-51)  / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (0078-0628-61)", "package_ndc": "0078-0628-51", "marketing_start_date": "20120829"}], "brand_name": "Afinitor Disperz", "product_id": "0078-0628_79d3253f-e1e3-428f-8dd4-4f2fe76faa15", "dosage_form": "TABLET, FOR SUSPENSION", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Immunologic Activity [PE]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]", "mTOR Inhibitor Immunosuppressant [EPC]", "mTOR Inhibitors [MoA]"], "product_ndc": "0078-0628", "generic_name": "everolimus", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Afinitor", "brand_name_suffix": "Disperz", "active_ingredients": [{"name": "EVEROLIMUS", "strength": "5 mg/1"}], "application_number": "NDA203985", "marketing_category": "NDA", "marketing_start_date": "20120829", "listing_expiration_date": "20271231"}